Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Analyze global market entry opportunities
  • Find generic sources and suppliers

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

DrugPatentWatch Database Preview

Atropine sulfate - Generic Drug Details

« Back to Dashboard

What are the generic drug sources, and freedom to operate, for atropine sulfate?

Atropine sulfate is the generic ingredient in eighteen branded drugs marketed by Hospira, Novartis Pharms Corp, Us Army, Akorn, Sebela Ireland Ltd, Sun Pharm Inds, West-ward Pharms Int, Inwood Labs, Vangard, Sandoz, Halsey, Ani Pharms Inc, Parke Davis, Ascot, Medpointe Pharm Hlc, R And S Pharma, Scherer Rp, Usl Pharma, Alpharma Us Pharms, Lederle, Par Pharm, Roxane, Kv Pharm, Mylan, Superpharm, Gd Searle Llc, Hikma Pharms Llc, Md Pharm, Pvt Form, Lannett, Watson Labs, Able, Valeant Pharm Intl, Heather, Mylan Institutional, Wyeth Ayerst, and Abbvie, and is included in forty-three NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are twenty-two drug master file entries for atropine sulfate. Five suppliers are listed for this compound.

Summary for Generic Name: atropine sulfate

Drug Master File Entries: see list22
Suppliers / Packagers: see list5
Bulk Api Vendors: see list166
Clinical Trials: see list348
Patent Applications: see list17,496
Therapeutic Class:Gastrointestinal Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:atropine sulfate at DailyMed

Pharmacology for Ingredient: atropine sulfate

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hikma Pharms Llc
atropine sulfate; diphenoxylate hydrochloride
TABLET;ORAL087765-001Mar 15, 1982DISCNNoNo► Subscribe► Subscribe
Kv Pharm
atropine sulfate; diphenoxylate hydrochloride
TABLET;ORAL085659-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
atropine sulfate; diphenoxylate hydrochloride
TABLET;ORAL088962-001May 10, 1985DISCNNoNo► Subscribe► Subscribe
Scherer Rp
atropine sulfate; diphenoxylate hydrochloride
CAPSULE;ORAL086440-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
atropine sulfate; diphenoxylate hydrochloride
TABLET;ORAL086950-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.